GS-441524 is a nucleoside analogue antiviral compound commonly referenced in veterinary antiviral protocols associated with feline infectious peritonitis (FIP). As treatment approaches for FIP continue to evolve, oral tablet formulations have become an important option for cats requiring long-term antiviral management.
This product contains 20mg GS-441524 per tablet and is designed for oral administration in veterinary care environments. Compared with injectable formulations, tablets may offer a more convenient administration method for caregivers managing extended treatment schedules.
Feline infectious peritonitis develops from mutations of feline coronavirus within the cat’s body. Once the mutated virus spreads through immune cells, systemic inflammation may occur in organs such as the liver, kidneys, abdomen, eyes, and nervous system. Because the disease may present differently from one cat to another, treatment protocols are typically adjusted according to body weight and clinical symptoms.
The 20mg tablet strength provides flexible dosage control, particularly for smaller cats, kittens, or situations where gradual dosage adjustment is preferred. The product is manufactured under controlled production standards and packaged for stable storage and transportation.
| Parameter | Details |
|---|---|
| Product Name | GS-441524 Tablets |
| Active Ingredient | GS-441524 |
| Strength | 20mg per tablet |
| Dosage Form | Oral Tablets |
| Intended Use | Cat FIP Support |
| Storage Condition | Room Temperature |
| Shelf Life | 12 Months |
| Country of Manufacture | China |
Each package includes manufacturing batch information and expiration labeling for traceability purposes.
FIP is considered one of the most serious infectious diseases affecting cats. It originates from feline coronavirus (FCoV), which is commonly present in multi-cat environments. While many cats infected with feline coronavirus show mild or no symptoms, viral mutation can occasionally lead to systemic disease.
Veterinary medicine generally classifies FIP into multiple clinical forms.
Wet FIP is often associated with fluid accumulation in the abdomen or chest cavity. Cats may show signs such as swollen abdomen, reduced appetite, or breathing difficulty.
Dry FIP commonly affects internal organs without obvious fluid buildup. Symptoms may develop gradually and vary between patients.
Eye involvement may include inflammation, iris discoloration, or visual disturbances.
Neurological forms may affect coordination, balance, and nervous system function.
Because clinical presentations differ significantly, antiviral dosage plans are commonly adjusted according to disease severity and body weight.
The 20mg tablet strength allows easier adjustment for cats requiring lower daily antiviral intake. This may be particularly useful for smaller body weight ranges.
Tablet administration may reduce the stress associated with repeated injections, especially during long-term treatment cycles.
Oral formulations are frequently considered during stabilization or maintenance phases of antiviral treatment programs.
Each batch is produced under controlled manufacturing procedures to help maintain stable tablet quality and ingredient consistency.
The tablets are designed for room-temperature storage, simplifying transportation and routine handling.
GS-441524 tablet dosage is usually determined according to body weight and the clinical type of FIP involved.
General treatment considerations may include:
| FIP Type | Dosage Consideration |
|---|---|
| Wet FIP | Standard oral antiviral support |
| Dry FIP | Moderate dosage adjustment may be required |
| Ocular FIP | Increased support protocols may be considered |
| Neurological FIP | Higher antiviral coverage may be necessary |
| Relapse Cases | Ongoing monitoring and dosage review |
Treatment duration and protocol adjustments should be evaluated according to veterinary supervision and clinical response.
Veterinarians may include oral GS-441524 tablets as part of structured FIP management plans.
Rescue groups caring for young or vulnerable cats may use oral antiviral support during rehabilitation and monitoring periods.
Some cat owners prefer tablets because oral administration may be easier to manage during daily treatment routines.
Professional breeding facilities sometimes require antiviral management strategies when infectious diseases affect feline populations.
To maintain product quality and stability:
Under recommended conditions, the tablets maintain stability for up to 12 months from the manufacturing date.
GS-441524 20mg tablets are packaged for veterinary supply and feline antiviral management programs. Protective packaging is used during transportation to maintain tablet integrity.
Common supply channels include:
